Cargando…
Corrigendum: Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322943/ https://www.ncbi.nlm.nih.gov/pubmed/34335283 http://dx.doi.org/10.3389/fphar.2021.732903 |
| _version_ | 1783731148065603584 |
|---|---|
| author | Ladin, Daniel A. Soliman, Eman Griffin, LaToya Van Dross, Rukiyah |
| author_facet | Ladin, Daniel A. Soliman, Eman Griffin, LaToya Van Dross, Rukiyah |
| author_sort | Ladin, Daniel A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8322943 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-83229432021-07-31 Corrigendum: Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents Ladin, Daniel A. Soliman, Eman Griffin, LaToya Van Dross, Rukiyah Front Pharmacol Pharmacology Frontiers Media S.A. 2021-07-16 /pmc/articles/PMC8322943/ /pubmed/34335283 http://dx.doi.org/10.3389/fphar.2021.732903 Text en Copyright © 2021 Ladin, Soliman, Griffin and Van Dross. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Pharmacology Ladin, Daniel A. Soliman, Eman Griffin, LaToya Van Dross, Rukiyah Corrigendum: Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents |
| title | Corrigendum: Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents |
| title_full | Corrigendum: Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents |
| title_fullStr | Corrigendum: Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents |
| title_full_unstemmed | Corrigendum: Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents |
| title_short | Corrigendum: Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents |
| title_sort | corrigendum: preclinical and clinical assessment of cannabinoids as anti-cancer agents |
| topic | Pharmacology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322943/ https://www.ncbi.nlm.nih.gov/pubmed/34335283 http://dx.doi.org/10.3389/fphar.2021.732903 |
| work_keys_str_mv | AT ladindaniela corrigendumpreclinicalandclinicalassessmentofcannabinoidsasanticanceragents AT solimaneman corrigendumpreclinicalandclinicalassessmentofcannabinoidsasanticanceragents AT griffinlatoya corrigendumpreclinicalandclinicalassessmentofcannabinoidsasanticanceragents AT vandrossrukiyah corrigendumpreclinicalandclinicalassessmentofcannabinoidsasanticanceragents |